Cargando…
A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
BACKGROUND: Dengue has emerged as the most significant of arboviral diseases in the 21st century. It is endemic to >100 tropical and sub-tropical countries around the world placing an estimated 3.6 billion people at risk. It is caused by four genetically similar but antigenically distinct, seroty...
Autores principales: | Raut, Rajendra, Beesetti, Hemalatha, Tyagi, Poornima, Khanna, Ira, Jain, Swatantra K, Jeankumar, Variam U, Yogeeswari, Perumal, Sriram, Dharmarajan, Swaminathan, Sathyamangalam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327787/ https://www.ncbi.nlm.nih.gov/pubmed/25886260 http://dx.doi.org/10.1186/s12985-015-0248-x |
Ejemplares similares
-
An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes
por: Khanam, Saima, et al.
Publicado: (2007) -
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
por: Arora, Upasana, et al.
Publicado: (2012) -
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
por: Tripathi, Lav, et al.
Publicado: (2015) -
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020) -
Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes
por: Sood, Ruchi, et al.
Publicado: (2015)